Concepedia

Mirosław Majewski

MM

Statistics

Publications

21

Citations

1.7K

H-Index

17

Active since

1997

Affiliations

University of Pennsylvania(Current)

Instytut Hematologii i Transfuzjologi

Sidney Kimmel Cancer Center

Medical University of Silesia

Nicolaus Copernicus University

Mirosław Majewski is an author at University of Pennsylvania specializing in life sciences, oncology, and molecular oncology.

Publications per year

1997–2012

21

Publications

21

Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma

Qian Zhang, Puthryaveett N. Raghunath, Liquan Xue et al. · The Journal of Immunology · 2002 · 261 citations

Medicine, Cancer Biology, Oncology +15

Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.

Malgorzata Nieborowska-Skorska, Grażyna Hoser, Andrea Morrione et al. · PubMed · 2001 · 260 citations

Life Sciences, Molecular Biology, Oncology +17

The immunosuppressive macrolide RAD inhibits growth of human Epstein–Barr virus-transformed B lymphocytes <i>in vitro</i> and <i>in vivo</i> : A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

Mirosław Majewski, Magdalena Korecka, Plamen Kossev et al. · Proceedings of the National Academy of Sciences · 2000 · 214 citations

Life Sciences, Immunology, Pathology +15

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

Mirosław Majewski, Magdalena Korecka, Joanne Joergensen et al. · Transplantation · 2003 · 156 citations

Medicine, Pharmacology, Pharmacotherapy +17

Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.

Mirosław Majewski, Malgorzata Nieborowska-Skorska, Paolo Salomoni et al. · PubMed · 1999 · 128 citations

Life Sciences, Cell Biology, Oncology +16

1–5 of 21